Arcadia Biosciences, Inc. (RKDA): auditor change — Arcadia Biosciences dismisses Deloitte, hires RJI as new auditor; cites material weaknesses

Arcadia Biosciences, Inc.

Dismissed Deloitte & Touche on March 30, 2026; engaged Ramirez Jimenez International CPAs (RJI) same day.
Deloitte's reports for 2024-2025 included going concern doubt due to accumulated deficit and recurring net losses.
No disagreements with Deloitte, but material weaknesses in internal controls (segregation of duties, IT controls) existed as of Dec 31, 2025.
RJI will handle Q1 2026 review and FY 2026 audit; no prior consultations with RJI on accounting matters.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Arcadia Biosciences, Inc. engaged Ramirez Jimenez International CPAs as its auditor.

Action: engagement
Auditor: Ramirez Jimenez International CPAs

Exact text from the filing

the Audit Committee approved the engagement of Ramirez Jimenez International CPAs (“RJI”), effective immediately upon the dismissal of Deloitte, as the Company’s independent registered public accounting firm

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Arcadia Biosciences, Inc. dismissed Deloitte & Touche LLP as its auditor.

Action: dismissal
Auditor: Deloitte & Touche LLP
Successor: Ramirez Jimenez International CPAs

Exact text from the filing

dismissed Deloitte & Touche LLP (“Deloitte”) as the Company’s independent registered public accounting firm.

View on SEC.gov

Browse all auditor changes →

Arcadia Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-142030

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.